GUTS רווח נקי למניה ב-12 החודשים האחרונים fractyl.com
Fractyl Health, Inc. (GUTS) is developing medical logistics to ensure the rapid delivery of therapy systems to clinics. The change in rolling net income per share visualizes the financial dynamics, where the -5.73 parameter determines the metric's magnitude. Fractyl Health, Inc. (GUTS) is implementing the Revita method for the natural restoration of metabolism in type 2 diabetes. However, high R&D costs and dependence on test results necessitate strict liquidity control.
%20%D7%A8%D7%95%D7%95%D7%97%20%D7%9C%D7%9E%D7%A0%D7%99%D7%94%20%D7%91%D7%90%D7%A8%D7%91%D7%A2%D7%AA%20%D7%94%D7%A8%D7%91%D7%A2%D7%95%D7%A0%D7%99%D7%9D%20%D7%94%D7%90%D7%97%D7%A8%D7%95%D7%A0%D7%99%D7%9D&width=1200&height=400&colorIndex=0&v=mwg3sw3k.w4s-7di3ke8&start=20220704&end=20261114&filename=GURU_Markets_-_GUTS_-_Fractyl-Health-Inc._-_Earnings-per-share-for-the-last-four-quarters "Fractyl - רווח נקי למניה (EPS TTM) GUTS (תקופה 21.02.2024 - 14.11.2026) | 👁️GURU.Markets👁️")
פילוחים אנליטיים ודוחות נתונים של חברת Fractyl Health Inc. (GUTS)
Fractyl Health, Inc. (GUTS) develops innovative endoscopic systems for diabetes therapy, establishing a market for long-term consumable supplies. Earnings per share (EPS TTM) measures the portion of total income attributable to a single security over one year. This metric allows for an assessment of real capital management efficiency and the risk of overpaying for the asset. It is critical for investors to align the monetization rates of medical technologies with financial returns. An analysis of the annual earnings per share trend confirms the resilience of the business model.
